The Day In Review: Roche Picks Up Antibody Firm For $56.5 Million

April 2, 2007 -- Roche will buy California-based Therapeutic Human Polyclonals for $56.5 million; NeoPharm said its cancer drug failed a Phase II trial; NovaVax published results showing its virus-like particle (VLP) vaccine produced a robust response against avian flu; Cephalon was sent another approvable letter for Nuvigil, a treatment for daytime sleepiness; Impax Labs settled a patent dispute over its generic version of Oxycontin with Purdue Pharma; Abbott asked for US and European approval of Humira as a treatment for severe chronic plaque psoriasis; Alkermes is seeking approval of Vivitrol for alcohol dependence in the UK and Germany; and Merck received FDA approval of a diabetes drug that combines Januvia,and metformin. The Centient Biotech 200™ rose 8 points to 3887, an increase of .21%. More details...